glp 1 muscle loss and GLP-1R agonists use Most of the “muscle loss”
Description
Not only can they help with weight management , but they also offer a pathway to improved fertility by regulating insulin levels and potentially restoring ovulation
In January 2025, Novo Nordisk stated that the United States Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease progression, kidney failure (end-stage renal disease), and cardiovascular disease-related death in individuals with type 2 diabetes and chronic kidney disease (CKD)
Staff responses vary by person one script + one follow up cadence keeps messaging consistent
It should be emphasized that the DPP4 enzyme can cleave various substrates in controlled laboratory conditions [124, 136]
Type 2 diabetes is driven by a combination of insulin resistance, reduced insulin production over time, and excess glucose output from the liver
